Method for the determination of the concentration of asymmetric dimethylarginine

Elevated plasma levels of ADMA are described for a number of diseases as hypertension, hypercholesterolemia, renal insufficiency or diabetes mellitus. The invention provides a method for the simultaneous determination of the concentration of asymmetric dimethylarginine (ADMA), arginine and symmetric dimethylarginine (SDMA) in biological probes using chromatography combined with tandem mass spectrometry.

Further Information: PDF

ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20

Contact
Peter Lösler

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors